Federal Register / Vol. 83, No. 134 / Thursday, July 12, 2018 / Notices 32313 

present them through a single 

representative. No audiovisual 

presentations are permitted. Written 

comments should identify the 

individual’s name, address, email, 

telephone number, professional or 

organization affiliation, background or 

area of expertise (i.e., parent, family 

member, researcher, clinician, public 

health, etc.) and the topic/subject 

matter. 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–14908 Filed 7–11–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Center for 

Advancing Translational Sciences. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cures Acceleration 

Network Review Board. 

Date: September 27, 2018. 

Time: 8:30 a.m. to 3:00 p.m. 

Agenda: Report from the Institute Director. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, 1 

Democracy Plaza, Room 1072, Bethesda, MD 

20892, 301–435–0809, annn.ramseyewing@

nih.gov. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: September 27, 2018. 

Open: 8:30 a.m. to 3:00 p.m. 

Agenda: Report from the Institute Director 

and other staff. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Closed: 3:15 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, 1 

Democracy Plaza, Room 1072, Bethesda, MD 

20892, 301–435–0809, anna.ramseyewing@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: July 5, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–14873 Filed 7–11–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the ZAT1 PJ (02) 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; Mechanisms of 

Mind and Body Interventions (MMB). 

Date: August 1, 2018. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Pamela Eugenia Jeter, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, Division of Extramural 

Activities, NCCIH, NIH, 6707 Democracy 

Boulevard, Suite 401, Bethesda, MD 20892, 

301–435–2591, pamela.jeter@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Integrative Health, 

National Institutes of Health, HHS) 

Dated: July 6, 2018. 

Michelle D. Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–14874 Filed 7–11–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Accreditation and Approval of Saybolt 

LP (Nederland, TX) as a Commercial 

Gauger and Laboratory 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: Notice of accreditation and 

approval of Saybolt LP (Nederland, TX) 

as a commercial gauger and laboratory. 

SUMMARY: Notice is hereby given, 

pursuant to CBP regulations, that 

Saybolt LP (Nederland, TX) has been 

approved to gauge petroleum and 

certain petroleum products and 

accredited to test petroleum and certain 

petroleum products for customs 

purposes for the next three years as of 

August 8, 2017. 

DATES: Saybolt LP (Nederland, TX) was 

approved and accredited as a 

commercial gauger and laboratory as of 

August 8, 2017. The next triennial 

inspection date will be scheduled for 

August 2020. 

FOR FURTHER INFORMATION CONTACT: 

Christopher J. Mocella, Laboratories and 

Scientific Services Directorate, U.S. 

Customs and Border Protection, 1300 

Pennsylvania Avenue NW, Suite 1500N, 

Washington, DC 20229, tel. 202–344– 

1060. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given pursuant to 19 CFR 151.12 

and 19 CFR 151.13, that Saybolt LP, 

4144 N Twin City Hwy., Nederland, TX 

77627, has been approved to gauge 

petroleum and certain petroleum 

products and accredited to test 

petroleum and certain petroleum 

products for customs purposes, in 

accordance with the provisions of 19 

CFR 151.12 and 19 CFR 151.13. Saybolt 


amozie on DSK3GDR082PROD with NOTICES1